focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,020.00
Bid: 1,020.50
Ask: 1,021.00
Change: 2.00 (0.20%)
Spread: 0.50 (0.049%)
Open: 1,024.50
High: 1,030.00
Low: 1,017.50
Prev. Close: 1,018.00
SN. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

30 Aug 2016 17:36

RNS Number : 4721I
Smith & Nephew Plc
30 August 2016
 

30 August 2016

Smith & Nephew plc (the "Company")

 

Transaction in Own Shares

 

The Company today purchased 300,000 of its Ordinary Shares of US 20¢ each through Merrill Lynch International, in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 14 April 2016. These shares have been purchased as part of the $300 million buy-back programme, the purpose for which is to reduce the Company's share capital, as announced on 8 August 2016. Details of the relevant purchase transactions are set out below:

 

 

Description of Shares:

Smith & Nephew Ordinary Shares of US 20¢ each

Number of Shares repurchased:

300,000

Average price paid per Share:

1,233.9815p

Highest price paid per Share:

1,240.0000p

Lowest price paid per Share:

1,225.0000p

Date of transaction:

30 August 2016

Broker:

Merrill Lynch International

 

 

The Company intends to hold these shares in Treasury.

 

Following the purchase of these shares, the Company holds 21,383,262 of its shares in Treasury. The Company's issued share capital, with one voting right per share consists of 892,010,847 Ordinary Shares of US20¢ each (excluding treasury shares). This is the figure which should be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

These purchases were made by Merrill Lynch International on behalf of the Company and a full breakdown of the individual trades is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/4721I_-2016-8-30.pdf

 

This announcement is made in accordance with the requirements of LR 12.4.6.

 

 

Elaine Richardson

Deputy Company Secretary

Smith & Nephew plc

Tel: 01923 477320

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSSDDFMSFMSEDA
Date   Source Headline
12th Mar 201812:18 pmRNSDirector/PDMR Shareholding
8th Mar 20181:20 pmRNSDirector/PDMR Shareholding
8th Mar 20181:15 pmRNSDirector/PDMR Shareholding
6th Mar 20182:59 pmRNSTransaction in Own Shares
5th Mar 20184:30 pmRNSAnnual Financial Report
1st Mar 201812:29 pmRNSDirectorate Change
1st Mar 201810:54 amRNSTotal Voting Rights
27th Feb 20183:55 pmRNSDirector/PDMR Shareholding
15th Feb 20185:43 pmRNSTransaction in Own Shares
14th Feb 20186:10 pmRNSTransaction in Own Shares
13th Feb 20184:11 pmRNSDirector/PDMR Shareholding
12th Feb 20189:15 amRNSTransaction in Own Shares
9th Feb 201812:20 pmRNSDirector/PDMR Shareholding
8th Feb 20184:49 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSFinal Results
7th Feb 20189:33 amRNSSmith & Nephew announces European launch of PICO 7
2nd Feb 201810:31 amRNSBlock listing Interim Review
1st Feb 20181:40 pmRNSTotal Voting Rights
31st Jan 20189:06 amRNSAppointment of Roland Diggelmann as Non-Exec. Dir.
23rd Jan 201812:00 pmRNSSmith & Nephew update on tax
9th Jan 20184:34 pmRNSDirector/PDMR Shareholding
4th Jan 20184:03 pmRNSDirector Declaration
2nd Jan 20182:33 pmRNSTotal Voting Rights
6th Dec 20172:19 pmRNSSmith & Nephew pilot digital wound care solution
6th Dec 20177:00 amRNSAcquisition of Rotation Medical Inc
1st Dec 20173:09 pmRNSTotal Voting Rights
22nd Nov 201710:25 amRNSDirector/PDMR Shareholding
15th Nov 20173:29 pmRNSTransaction in Own Shares
15th Nov 20178:00 amRNSNew RCT demonstrates effectiveness of ALLEVYN LIFE
13th Nov 20175:00 pmRNSDirector/PDMR Shareholding
13th Nov 20171:00 pmRNSLaunch of robotics-assisted knee replacement
13th Nov 20179:55 amRNSDirector/PDMR Shareholding
8th Nov 20176:03 pmRNSTransaction in Own Shares
8th Nov 201710:31 amRNSDirector/PDMR Shareholding
7th Nov 20175:47 pmRNSTransaction in Own Shares
6th Nov 20172:10 pmRNSTransaction in Own Shares
3rd Nov 20177:00 amRNSTrading Statement
2nd Nov 201712:13 pmRNSDirector/PDMR Shareholding
1st Nov 20171:55 pmRNSTotal Voting Rights
1st Nov 20171:43 pmRNSDirector/PDMR Shareholding
23rd Oct 20172:00 pmRNSAcquisition of tissue regeneration technology
19th Oct 201710:10 amRNSDividend Declaration
13th Oct 20179:00 amRNSNotice of Results
10th Oct 20174:21 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSRetirement of Chief Executive Officer by end 2018
4th Oct 20178:00 amRNSWound Expert Panel Report
2nd Oct 201710:24 amRNSTotal Voting Rights
2nd Oct 20179:00 amRNSDirectorate Change
18th Sep 20179:42 amRNSDirectorate Change
12th Sep 20174:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.